Say hello to MassDevice +3Blogs, a bite-sized view of the top three med-tech blogs of the week. This latest feature of MassDevice.com’s coverage highlights our three favorite blogs of the week to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +3Blogs.
Starting November 1, 2011, Health Canada will extend a pilot program requiring both paper and electronic submissions of premarket review documents for Class IV medical devices to Class III devices, as well, reported Stewart Eisenhart of the Emergo Group.
The implications to policy makers who use such trendy buzz phrases like “continuous improvement” is that doctors and current public policy workers aren’t already working to constantly improve our patients’ health. Instead, we are messy, doing expensive things that involve too much time and too much money, reported cardiologist Westby Fisher.
Could you also view cancer as a metabolic disorder, like type 2 diabetes? George Daley and his lab in the Stem Cell Transplantation Program at Children’s have found some intriguing molecular links that make this a plausible idea, reported Children’s Hospital Boston’s Tom Ulrich.